首頁 > 市場調查報告書 > 材料

市場調查報告書

商品編碼

1696654

菸鹼醯胺單核苷酸 (NMN) 市場報告：2031 年趨勢、預測與競爭分析

Nicotinamide Mononucleotide (NMN) Market Report: Trends, Forecast and Competitive Analysis to 2031

出版日期: 2025年03月28日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球菸鹼醯胺單核苷酸（NMN）市場前景廣闊，在醫療產品和化妝品市場都存在機會。預計全球菸鹼醯胺單核苷酸 (NMN) 市場從 2025 年到 2031 年的複合年成長率將達到 7.9%。該市場的主要驅動力是人們對健康和保健的日益關注，加上消費者對預防性醫療保健重要性的認知不斷提高，正在進行的研究和臨床研究探索 NMN 的潛在健康益處，以及人們對抗衰老產品和補充劑的興趣日益濃厚。

Lucintel 預測，按類型分類，98% 以上的含量預計在預測期內將出現高速成長。
從應用來看，醫療產品預計將出現強勁成長。
根據地區，預計北美將在預測期內實現最高成長。

菸鹼醯胺單核苷酸（NMN）市場的策略成長機會

NMN 市場由消費者對健康和保健產品的需求所驅動，並在關鍵應用領域呈現出各種策略性成長機會。識別這些機會可以顯著提高您的市場佔有率。

膳食補充劑：NMN 的主要用途是作為膳食補充劑，需求正在迅速成長。隨著消費者尋求天然的抗衰老解決方案，該行業正在經歷顯著成長，為製造商提供了創新的機會。
機能性食品和飲料：含有NMN的機能性食品和飲料市場正在擴大。這一趨勢迎合了尋求便捷健康解決方案的消費者的需求，並將擴大 NMN 產品在日常飲食中的滲透率。
個人保健產品：將 NMN 納入護膚等個人保健產品中，提供了獨特的成長機會。隨著消費者越來越注重整體健康，NMN 對皮膚健康的潛在益處可能會推動新產品的開發。
藥物應用：隨著NMN治療效果的研究不斷進展，它可能為其在藥物領域的應用鋪平道路。如果研究檢驗NMN 的有效性，那麼與製藥公司的合作就有可能促成基於 NMN 的藥物的開發。
拓展全球市場：隨著人們健康意識的增強，向新興市場（尤其是亞洲和非洲）擴張提供了成長機會。公司可以利用當地的夥伴關係來增加分銷並接觸新的消費者群體。

這些成長機會正在再形成NMN市場，刺激創新並擴大多個領域的應用。

菸鹼醯胺單核苷酸（NMN）市場促進因素與挑戰

NMN 市場受到各種促進因素和挑戰的影響，包括技術、經濟和監管因素。了解這些動態對於相關人員駕馭這個不斷發展的市場至關重要。

菸鹼醯胺單核苷酸（NMN）市場受以下因素驅動：

對抗老化產品的興趣日益濃厚：消費者對抗老化和保健產品的興趣日益濃厚是 NMN 需求的主要驅動力。隨著越來越多的人尋求改善健康和延長壽命，NMN 越來越被視為一種有價值的補充劑。
科學研究和檢驗：正在進行的研究證實了 NMN 的健康益處，增加了消費者的信任和興趣。這種科學支持鼓勵了市場投資和創新。
不斷增強的健康意識：隨著消費者的健康意識不斷增強，對 NMN 等天然有效的膳食補充劑的需求也在成長。這一趨勢支持了整體市場的成長和產品多樣化。
監管支援：良好的膳食補充劑法規使公司能夠有效地行銷 NMN 產品。這種清晰度可以增強消費者的信任並推動銷售成長。
電子商務的成長：網路購物的興起增加了獲得 NMN 產品的管道，使消費者可以輕鬆探索和購買補充劑。這一趨勢對於市場擴張至關重要。

菸鹼醯胺單核苷酸（NMN）市場面臨的挑戰如下：

市場飽和：隨著越來越多的 NMN 產品進入市場，市場可能會變得飽和，品牌將很難實現差異化。為了脫穎而出並保持競爭優勢，公司必須創新。
監管障礙：對於製造商來說，遵守不同地區的複雜法規可能是一個挑戰。遵守各種標準需要資源，並且會影響打入市場策略。
消費者懷疑：儘管興趣日益濃厚，但一些消費者仍然對 NMN 產品的有效性持懷疑態度。教育市場和建立信任對於克服這項挑戰至關重要。

這些促進因素和挑戰將對 NMN 市場產生重大影響，塑造其未來前景並決定成長和創新策略。

宏觀經濟趨勢（2019-2024）及預測（2025-2031）
全球菸鹼醯胺單核苷酸（NMN）市場趨勢（2019-2024）及預測（2025-2031）
全球菸鹼醯胺單核苷酸（NMN）市場類型
- 含量98%以上
- 含量低於98%
全球菸鹼醯胺單核苷酸（NMN）市場應用情況
- 醫療產品
- 化妝品
- 其他

第4章區域市場趨勢與預測分析（2019-2031）

全球菸鹼醯胺單核苷酸（NMN）市場（按地區）
北美菸鹼醯胺單核苷酸（NMN）市場
歐洲菸鹼醯胺單核苷酸（NMN）市場
亞太菸鹼醯胺單核苷酸（NMN）市場
世界其他地區的菸鹼醯胺單核苷酸（NMN）市場

第5章競爭分析

產品系列分析
營運整合
波特五力分析

第6章成長機會與策略分析

成長機會分析
- 全球菸鹼醯胺單核苷酸（NMN）市場成長機會（按類型）
- 全球菸鹼醯胺單核苷酸（NMN）市場成長機會（按應用）
- 全球菸鹼醯胺單核苷酸（NMN）市場成長機會（按地區）
全球菸鹼醯胺單核苷酸（NMN）市場的新興趨勢
戰略分析
- 新產品開發
- 全球菸鹼醯胺單核苷酸（NMN）市場產能擴張
- 全球菸鹼醯胺單核苷酸 (NMN) 市場的企業合併
- 認證和許可

第7章主要企業簡介

GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac

簡介目錄

The future of the global nicotinamide mononucleotide (NMN) market looks promising, with opportunities in the health care product and cosmetic markets. The global nicotinamide mononucleotide (NMN) market is expected to grow with a CAGR of 7.9% from 2025 to 2031. The major drivers for this market are the growing focus on health and wellness, coupled with rising consumer awareness about the importance of preventive healthcare, ongoing research and clinical studies exploring the potential health benefits of NMN, as well as increasing interest in anti-aging products and supplements.

Lucintel forecasts that, within the type category, content greater than or equal to 98% is expected to witness higher growth over the forecast period.
Within the application category, healthcare product is expected to witness higher growth.
In terms of regions, North America is expected to witness the highest growth over the forecast period.

Gain valuable insight for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Nicotinamide Mononucleotide (NMN) Market

The NMN market is undergoing transformative trends driven by scientific research, consumer awareness, and technological advancements. These trends are reshaping how NMN is perceived and utilized in health and wellness.

Increased Research and Development: Ongoing scientific studies are validating the health benefits of NMN, particularly in aging and metabolic health. As research continues to affirm its efficacy, consumer confidence in NMN products is growing, leading to increased demand and market expansion.
Focus on Bioavailability: There is a growing emphasis on improving the bioavailability of NMN supplements. Innovations in formulation and delivery methods are being developed to enhance absorption, making products more effective and appealing to health-conscious consumers.
Consumer Education and Awareness: As knowledge about NMN spreads, consumers are becoming more informed about its potential benefits. Educational campaigns and marketing strategies are crucial for companies to build trust and attract a broader customer base, enhancing market growth.
Sustainability Practices: Manufacturers are increasingly adopting sustainable sourcing and production practices in response to consumer demand for eco-friendly products. This trend not only appeals to environmentally conscious consumers but also strengthens brand loyalty and market positioning.
Diversification of Product Offerings: The NMN market is seeing a diversification of products, including capsules, powders, and functional foods. This variety caters to different consumer preferences and lifestyles, broadening the market reach and increasing overall sales.

These trends are reshaping the NMN market, driving innovation, consumer engagement, and sustainability efforts.

Recent Developments in the Nicotinamide Mononucleotide (NMN) Market

Recent developments in the NMN market highlight significant advancements in research, product formulations, and consumer engagement. These changes are crucial for market growth and competitiveness.

Scientific Validation: Recent studies demonstrating the benefits of NMN for aging and metabolism are driving interest among consumers and investors. This validation is encouraging companies to invest in NMN research, enhancing credibility and market acceptance.
Innovative Formulations: Companies are focusing on developing innovative NMN formulations that enhance bioavailability and absorption. These advancements improve product efficacy, attracting more consumers seeking effective health solutions.
Regulatory Advancements: Increased clarity in dietary supplement regulations is fostering a favorable environment for NMN products. This regulatory support enables companies to market their products more effectively, boosting consumer confidence and sales.
Strategic Partnerships: Collaborations between manufacturers and research institutions are fostering innovation in NMN product development. These partnerships enhance R&D capabilities, leading to improved formulations and better market offerings.
Expansion into New Markets: Companies are exploring opportunities in emerging markets for NMN supplements. This expansion strategy aims to tap into the growing global interest in health and wellness, driving overall market growth.

These developments are positively impacting the NMN market, enhancing its credibility, accessibility, and product offerings.

Strategic Growth Opportunities for Nicotinamide Mononucleotide (NMN) Market

The NMN market presents various strategic growth opportunities across key applications, driven by consumer demand for health and wellness products. Identifying these opportunities can significantly enhance market presence.

Dietary Supplements: The primary application for NMN is in dietary supplements, where demand is rapidly increasing. As consumers seek natural anti-aging solutions, this segment is poised for significant growth, offering manufacturers ample opportunities to innovate.
Functional Foods and Beverages: There is a growing market for functional foods and beverages infused with NMN. This trend caters to consumers looking for convenient health solutions, expanding the reach of NMN products into everyday diets.
Personal Care Products: The incorporation of NMN into personal care products, such as skincare, presents a unique growth opportunity. As consumers increasingly focus on holistic wellness, NMN's potential benefits for skin health can drive new product developments.
Pharmaceutical Applications: Research into NMN's therapeutic benefits may open doors for pharmaceutical applications. As studies validate its efficacy, partnerships with pharmaceutical companies could lead to the development of NMN-based medications.
Global Market Expansion: Expanding into emerging markets, particularly in Asia and Africa, offers growth opportunities as health awareness rises. Companies can leverage local partnerships to enhance distribution and access new consumer bases.

These growth opportunities are reshaping the NMN market, driving innovation, and broadening its applications across various sectors.

Nicotinamide Mononucleotide (NMN) Market Driver and Challenges

The NMN market is influenced by various drivers and challenges, encompassing technological, economic, and regulatory factors. Understanding these dynamics is essential for stakeholders navigating this evolving market.

The factors responsible for driving the nicotinamide mononucleotide (NMN) market include the following:

Growing Interest in Anti-Aging Products: The rising consumer focus on anti-aging and wellness products significantly drives demand for NMN. As more people seek to enhance their health and longevity, NMN is increasingly viewed as a valuable supplement.
Scientific Research and Validation: Ongoing studies confirming the health benefits of NMN bolster consumer confidence and interest. This scientific backing encourages investment and innovation within the market.
Increased Health Awareness: As consumers become more health-conscious, there is a growing demand for natural and effective dietary supplements like NMN. This trend supports overall market growth and product diversification.
Regulatory Support: Favorable regulations regarding dietary supplements are enabling companies to market NMN products effectively. This clarity fosters consumer trust and drives sales growth.
E-commerce Growth: The rise of online shopping is enhancing accessibility to NMN products, allowing consumers to explore and purchase supplements conveniently. This trend is crucial for expanding market reach.

Challenges in the nicotinamide mononucleotide (NMN) market are:

Market Saturation: The increasing number of NMN products entering the market can lead to saturation, making it challenging for brands to differentiate themselves. Companies must innovate to stand out and maintain competitive advantages.
Regulatory Hurdles: Navigating complex regulations across different regions can pose challenges for manufacturers. Compliance with varying standards requires resources and can impact market entry strategies.
Consumer Skepticism: Despite growing interest, some consumers remain skeptical about the efficacy of NMN products. Educating the market and building trust are essential for overcoming this challenge.

These drivers and challenges significantly influence the NMN market, shaping its future landscape and determining strategies for growth and innovation.

List of Nicotinamide Mononucleotide (NMN) Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies, nicotinamide mononucleotide (NMN) companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the nicotinamide mononucleotide (NMN) companies profiled in this report include-

GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac

Nicotinamide Mononucleotide (NMN) by Segment

The study includes a forecast for the global nicotinamide mononucleotide (NMN) market by type, application, and region.

Nicotinamide Mononucleotide (NMN) Market by Type [Analysis by Value from 2019 to 2031]:

Content Greater than or Equal to 98%
Content Less than 98%

Nicotinamide Mononucleotide (NMN) Market by Application [Analysis by Value from 2019 to 2031]:

Health Care Products
Cosmetics
Others

Nicotinamide Mononucleotide (NMN) Market by Region [Analysis by Value from 2019 to 2031]:

North America
Europe
Asia Pacific
The Rest of the World

Country Wise Outlook for the Nicotinamide Mononucleotide (NMN) Market

The nicotinamide mononucleotide (NMN) market is experiencing significant growth as interest in anti-aging supplements and wellness products rises globally. Recent developments in the United States, China, Germany, India, and Japan highlight advancements in research, increased consumer awareness, and regulatory changes. The growing demand for NMN in dietary supplements and its potential health benefits are driving market expansion, prompting companies to innovate and improve product formulations. This dynamic landscape is attracting investments and fostering collaborations across the industry.

United States: In the US, the NMN market is expanding rapidly, driven by heightened consumer interest in longevity and health supplements. Recent research publications underscore NMN's potential benefits for cellular health and metabolism, spurring demand. Regulatory clarity regarding dietary supplements is also facilitating market growth, enabling companies to market NMN more effectively. E-commerce platforms are becoming key distribution channels, allowing consumers easier access to NMN products and further boosting sales.
China: China's NMN market is witnessing explosive growth as awareness of anti-aging benefits increases among consumers. The government is also supporting the health supplement industry through favorable regulations. Local manufacturers are investing in research and development to create high-quality NMN products that meet international standards. E-commerce continues to dominate sales channels, with numerous platforms offering a wide range of NMN supplements, making them readily available to consumers across the country.
Germany: In Germany, the NMN market is growing, driven by a strong focus on health and wellness. Recent studies highlighting NMN's benefits for aging and metabolism are increasing consumer interest. The regulatory landscape supports the health supplement sector, allowing for clearer labeling and marketing. Companies are emphasizing quality and sourcing, with an increasing demand for certified products, aligning with the German consumer's preference for transparency and sustainability in health products.
India: India's NMN market is in its nascent stages but is poised for growth due to rising health consciousness among consumers. Recent collaborations between manufacturers and research institutions are fostering innovation and product development. E-commerce platforms are becoming essential for distribution, providing consumers with access to a variety of NMN supplements. The government's initiatives promoting health and wellness are also creating a favorable environment for NMN products to thrive.
Japan: Japan's NMN market is characterized by a strong consumer interest in health and longevity products. Recent developments include the introduction of innovative NMN formulations aimed at enhancing absorption and efficacy. Regulatory support for health supplements is boosting market growth, encouraging manufacturers to develop high-quality products. The aging population is a significant driver of demand, with consumers increasingly seeking effective anti-aging solutions, further propelling the NMN market.

Features of the Global Nicotinamide Mononucleotide (NMN) Market

Market Size Estimates: Nicotinamide mononucleotide (NMN) market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Nicotinamide mononucleotide (NMN) market size by type, application, and region in terms of value ($B).

Regional Analysis: Nicotinamide mononucleotide (NMN) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the nicotinamide mononucleotide (NMN) market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the nicotinamide mononucleotide (NMN) market.

Analysis of the competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers the following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the nicotinamide mononucleotide (NMN) market by type (content greater than or equal to 98% and content less than 98%), application (health care products, cosmetics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market, and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years, and what has its impact been on the industry?

1. Executive Summary

2. Global Nicotinamide Mononucleotide (NMN) Market : Market Dynamics

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
3.2. Global Nicotinamide Mononucleotide (NMN) Market Trends (2019-2024) and Forecast (2025-2031)
3.3: Global Nicotinamide Mononucleotide (NMN) Market by Type
- 3.3.1: Content Greater than or Equal to 98%
- 3.3.2: Content Less than 98%
3.4: Global Nicotinamide Mononucleotide (NMN) Market by Application
- 3.4.1: Health Care Products
- 3.4.2: Cosmetics
- 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

4.1: Global Nicotinamide Mononucleotide (NMN) Market by Region
4.2: North American Nicotinamide Mononucleotide (NMN) Market
- 4.2.1: North American Market by Type: Content Greater than or Equal to 98% and Content Less than 98%
- 4.2.2: North American Market by Application: Health Care Products, Cosmetics, and Others
4.3: European Nicotinamide Mononucleotide (NMN) Market
- 4.3.1: European Market by Type: Content Greater than or Equal to 98% and Content Less than 98%
- 4.3.2: European Market by Application: Health Care Products, Cosmetics, and Others
4.4: APAC Nicotinamide Mononucleotide (NMN) Market
- 4.4.1: APAC Market by Type: Content Greater than or Equal to 98% and Content Less than 98%
- 4.4.2: APAC Market by Application: Health Care Products, Cosmetics, and Others
4.5: ROW Nicotinamide Mononucleotide (NMN) Market
- 4.5.1: ROW Market by Type: Content Greater than or Equal to 98% and Content Less than 98%
- 4.5.2: ROW Market by Application: Health Care Products, Cosmetics, and Others

5. Competitor Analysis

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Nicotinamide Mononucleotide (NMN) Market by Type
- 6.1.2: Growth Opportunities for the Global Nicotinamide Mononucleotide (NMN) Market by Application
- 6.1.3: Growth Opportunities for the Global Nicotinamide Mononucleotide (NMN) Market by Region
6.2: Emerging Trends in the Global Nicotinamide Mononucleotide (NMN) Market
6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Nicotinamide Mononucleotide (NMN) Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Nicotinamide Mononucleotide (NMN) Market
- 6.3.4: Certification and Licensing